Market Research Logo

Philippines Pharmaceuticals & Healthcare Q3 2018

Philippines Pharmaceuticals & Healthcare Q3 2018

BMI View:

The expansion of PhilHealth, with the aim of achieving universal coverage, will continue to be an important driver ofpharmaceuticals and healthcare market growth. While the country's disease profile will continue to evolve in line with economic anddemographic trends and will provide a number of revenue earning opportunities for pharmaceutical firms, a multitude of regulatoryissues will create challenges while policies implemented to control expenditure will become more prominent. The constraints onaffordability and the demand for low-cost pharmaceuticals will spur greater investment from drugmakers with strong generic drugportfolios.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drugs Market Forecast
Patented Drugs Market Forecast
Generic Drugs Market Forecast
OTC Medicines Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Pharmaceuticals: Divergent Regional Trends Will Shape Drugmaker Opportunities
Philippines Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
GlaxoSmithKline Philippines
Novartis
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report